DUSONCHET, Luisa
 Distribuzione geografica
Continente #
NA - Nord America 1.041
EU - Europa 583
AS - Asia 124
SA - Sud America 2
AF - Africa 1
Totale 1.751
Nazione #
US - Stati Uniti d'America 1.041
UA - Ucraina 157
IT - Italia 122
FI - Finlandia 92
CN - Cina 86
DE - Germania 47
IE - Irlanda 42
GB - Regno Unito 38
SE - Svezia 37
RU - Federazione Russa 20
IN - India 12
BE - Belgio 10
KR - Corea 10
FR - Francia 5
TR - Turchia 5
IR - Iran 4
RO - Romania 4
ES - Italia 3
AT - Austria 2
BR - Brasile 2
NL - Olanda 2
UZ - Uzbekistan 2
EG - Egitto 1
GR - Grecia 1
HK - Hong Kong 1
JP - Giappone 1
LB - Libano 1
LU - Lussemburgo 1
PK - Pakistan 1
VN - Vietnam 1
Totale 1.751
Città #
Fairfield 129
Ann Arbor 121
Chandler 102
Ashburn 87
Woodbridge 86
Jacksonville 68
Wilmington 58
Houston 51
Seattle 47
Cambridge 42
Dublin 39
Palermo 24
Medford 23
Nanjing 21
Princeton 17
Tulsa 15
Altamura 13
Boardman 12
Brussels 10
Des Moines 9
Lawrence 9
San Mateo 9
Seongnam 9
Shenyang 9
Nanchang 8
New York 8
Beijing 7
Dearborn 7
Milan 7
Tianjin 7
Ludwigshafen am Rhein 6
Verona 6
Auburn Hills 5
Changsha 5
Izmir 5
San Diego 5
Hebei 4
Jiaxing 4
Kilburn 4
Saint Petersburg 4
San Paolo di Civitate 4
Zhengzhou 4
London 3
Rome 3
Salamanca 3
Tehran 3
Islington 2
Jinan 2
Kunming 2
Los Angeles 2
Ningbo 2
Pune 2
Udupi 2
Washington 2
Amsterdam 1
Apo 1
Bologna 1
Bremen 1
Catania 1
Central District 1
Changchun 1
Chicago 1
Durham 1
Guangzhou 1
Haikou 1
Hangzhou 1
Hanoi 1
Hanover 1
Hefei 1
Helsinki 1
Indiana 1
Islamabad 1
Judenburg 1
Lanzhou 1
Manipal 1
Orange 1
Redwood City 1
San Francisco 1
San Giuliano 1
Siracusa 1
Taiyuan 1
Taizhou 1
Tappahannock 1
Temecula 1
Ürümqi 1
Totale 1.169
Nome #
Heterocyclic and Phenyl Double-Bond-Locked Combretastatin Analogues Possessing Potent Apoptosis-inducing activity in HL60 and in MDR Cell lines 199
Pterostilbene and 3'-hydroxypterostilbene are effective apoptosis-inducing agents in MDR and BCR-ABL-expressing leukemia cells 182
Histone deacetylase inhibition modulates deoxyribonucleotide pools and enhances the antitumor effects of the ribonucleotide reductase inhibitor 3’-C-methyladenosine in leukaemia cells 142
Galangin increases the cytotoxic activity of imatinib mesylate in imatinib-sensitive and imatinib-resistant Bcr-Abl expressing leukemia cells 137
Multidrug resistance reverting activity and antitumor profile of new phenothiazine derivatives 135
Expression of the IAPs in multidrug resistant tumor cells 135
Chemioterapici antibatterici 130
The synergistic apoptotic effects of thiophenfurin, an inosine monophosphate dehydrogenase inhibitor, in combination with retinoids in HL60 cells. 123
Resistance to gemcitabine in a lymphoma cell line resistant to Fas-mediated apoptosis 93
Expression of IAPs (Inhibitory of Apoptosis Proteins) and of their alternative splice variants in hepatocellular carcinoma tissues and cells 78
Epigenetic agents as an adjunct to active chemotherapy in hematological tumor cell lines 69
Histone deacetylase (HDAC) inhibitors potentiate the antiproliferative and apoptotic effects induced by the novel ribonucleotide reductase (RR) inhibitor 3'-metil-adenosine (3'-Me-Ado) in promyelocitic leukemia cell lines 67
Antitumor profile of new phenothiazine derivatives. 64
Antitumor effects of novel co-drugs linking histone deacetylase and ribonucleotide reductase inhibitors in hematological tumors 61
Hydroxamic acid-containing histone deacetylase inhibitors potentiate the antiproliferative and apoptotic effects induced by the ribonucleotide reductase R1 inhibitor 3'-C-methyl-adenosine in promyelocytic leukemia cell lines 57
Cytotoxic and apoptotic effects of thiophenfurin in combination with retinoids in human promyelocitic leucemia HL60 cells 53
Histone deacetylase (HDAC) inhibition modulates intracellular deoxynucleotides (dNTP) pools and potentiates the antitumor effects of the ribonucleotide reductase (RR) inhibitor 3’-Methyl-adenosine (3’-Me-Ado) in promyelocitic leukaemia cell lines. 52
Totale 1.777
Categoria #
all - tutte 5.236
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.236


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019107 0 0 0 0 0 0 0 0 0 17 42 48
2019/2020412 59 22 28 26 45 50 47 23 50 16 22 24
2020/2021265 9 33 9 22 44 7 25 9 41 15 25 26
2021/2022218 13 54 3 14 6 8 11 11 22 32 12 32
2022/2023257 31 48 1 35 33 39 6 19 31 1 9 4
2023/202487 4 18 4 5 6 20 16 13 0 1 0 0
Totale 1.777